
TY  - JOUR
TI  - E-Poster Presentations - B2) Pancreas
JO  - Journal of Gastroenterology and Hepatology
JA  - Journal of Gastroenterology and Hepatology
VL  - 32
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.13879
DO  - doi:10.1111/jgh.13879
SP  - 195
EP  - 209
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - s1
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2005.03000.x
DO  - doi:10.1111/j.1538-7836.2005.03000.x
SP  - H01
EP  - SYM90
PY  - 2005
ER  - 

TY  - JOUR
TI  - POSTER SESSION: CLINICAL
JO  - European Journal of Heart Failure
JA  - European Journal of Heart Failure
VL  - 12
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1093/eurjhf/hst009
DO  - doi:10.1093/eurjhf/hst009
SP  - S73
EP  - S325
PY  - 2013
ER  - 

TY  - JOUR
TI  - Published Only
JO  - Journal of Gastroenterology and Hepatology
VL  - 19
IS  - s5
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2004.03622.x
DO  - doi:10.1111/j.1440-1746.2004.03622.x
SP  - A501
EP  - A667
PY  - 2004
ER  - 

TY  - JOUR
TI  - Poster abstracts
JO  - HIV Medicine
VL  - 12
IS  - s1
SN  - 1464-2662
UR  - https://doi.org/10.1111/j.1468-1293.2011.00925.x
DO  - doi:10.1111/j.1468-1293.2011.00925.x
SP  - 14
EP  - 86
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12363_2
DO  - doi:10.1111/jgh.12363_2
SP  - 23
EP  - 693
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - The Journal of Dermatology
VL  - 39
IS  - s1
SN  - 0385-2407
UR  - https://doi.org/10.1111/j.1346-8138.2012.01624.x
DO  - doi:10.1111/j.1346-8138.2012.01624.x
SP  - 53
EP  - 280
PY  - 2012
ER  - 

TY  - JOUR
TI  - International Society of Paediatric Oncology, SIOP XXXVII Annual Congress Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 45
IS  - 4
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.20588
DO  - doi:10.1002/pbc.20588
SP  - 365
EP  - 608
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Transfusion Medicine
JA  - Transfusion Med
VL  - 25
IS  - s1
SN  - 0958-7578
UR  - https://doi.org/10.1111/tme.12183
DO  - doi:10.1111/tme.12183
SP  - 13
EP  - 54
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Session 1, Sunday 11 September
JO  - European Journal of Neurology
VL  - 18
IS  - s2
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2011.03551.x
DO  - doi:10.1111/j.1468-1331.2011.03551.x
SP  - 66
EP  - 343
PY  - 2011
ER  - 

TY  - JOUR
TI  - Wednesday 23rd July 2008
JO  - International Journal of Psychology
JA  - International Journal of Psychology
VL  - 43
IS  - 3-4
SN  - 0020-7594
UR  - https://doi.org/10.1080/00207594.2008.10108485
DO  - doi:10.1080/00207594.2008.10108485
SP  - 348
EP  - 527
PY  - 2008
ER  - 

TY  - JOUR
AU  - Ranta, N.
AU  - Turpeinen, H.
AU  - Oksanen, A.
AU  - Hämäläinen, S.
AU  - Huttunen, R.
AU  - Uusitalo-Seppälä, R.
AU  - Rintala, E.
AU  - Aittoniemi, J.
AU  - Pesu, M.
TI  - The Plasma Level of Proprotein Convertase FURIN in Patients with Suspected Infection in the Emergency Room: A Prospective Cohort Study
JO  - Scandinavian Journal of Immunology
JA  - Scand J Immunol
VL  - 82
IS  - 6
SN  - 0300-9475
UR  - https://doi.org/10.1111/sji.12386
DO  - doi:10.1111/sji.12386
SP  - 539
EP  - 546
PY  - 2015
AB  - Abstract There is an increasing need for novel biomarkers that enable better diagnostic and prognostic stratification of patients with suspected infection. A proprotein convertase enzyme FURIN is upregulated upon immune cell activation, and it promotes infectivity by cleaving and activating pathogens. In this study, we determined FURIN levels in plasma using ELISA from 537 patients that were admitted to emergency room with suspected infection. Patients were sorted to high- and low-level FURIN groups with a cut-off level of 370 pg/ml. The study cohort included five diagnostic groups: Group 1, no systemic inflammatory response syndrome (SIRS, n = 59 patients); Group 2, bacterial infection without SIRS (n = 67); Group 3, SIRS, but no bacterial infection (n = 308); Group 4, sepsis without organ failure (n = 308); and Group 5, severe sepsis (n = 49). Statistically significant associations were not found between the plasma level of FURIN and the prevalence of sepsis (P = 0.957), diagnostic group of a patient (P = 0.737) or the bacteria in blood culture (P = 0.499). Additionally, the concentration of FURIN did not predict the severity or case fatality of the infectious disease. However, statistically significant associations were found between high plasma level of FURIN and diagnosed rheumatic disease (P < 0.001) as well as with the prevalence of non-smokers (P = 0.034). Thus, albeit the plasma level of FURIN does not predict the severity of infectious disease, it may be of use in the diagnostics of autoimmune diseases.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 17
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.277
DO  - doi:10.1002/ejhf.277
SP  - 5
EP  - 441
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Display
JO  - International Journal of Paediatric Dentistry
VL  - 15
IS  - 5
SN  - 0960-7439
UR  - https://doi.org/10.1111/j.1365-263X.2005.00694.x
DO  - doi:10.1111/j.1365-263X.2005.00694.x
SP  - 397
EP  - 401
PY  - 2005
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 9
IS  - S1
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.1997.tb01080.x
DO  - doi:10.1111/j.1468-3083.1997.tb01080.x
SP  - S153
EP  - S238
PY  - 1997
ER  - 

TY  - JOUR
TI  - Poster Display
JO  - International Journal of Paediatric Dentistry
VL  - 15
IS  - s1
SN  - 0960-7439
UR  - https://doi.org/10.1111/j.1365-263X.2005.00691.x-i1
DO  - doi:10.1111/j.1365-263X.2005.00691.x-i1
SP  - 12
EP  - 16
PY  - 2005
ER  - 

AU  - Craighead, W. Edward
AU  - Craighead, Linda W.
AU  - Ritschel, Lorie A.
AU  - Zagoloff, Alexandra
TI  - Behavior Therapy and Cognitive-Behavioral Therapy
SN  - 9780470619049
UR  - https://doi.org/10.1002/9781118133880.hop208012
DO  - doi:10.1002/9781118133880.hop208012
KW  - behavior therapy
KW  - cognitive behavior therapy
KW  - behavioral activation
KW  - exposure and response prevention
KW  - dialectical behavior therapy
KW  - acceptance and commitment therapy
KW  - family-focused therapy
KW  - panic control therapy
KW  - transdiagnostic therapy
PY  - 2005
AB  - Abstract This chapter reviews the history of behavior therapy and the evolution of cognitive behavior therapy, and notes the emergence of the third-wave behavioral therapies, such as Acceptance and Commitment Therapy (ACT) and Dialectical Behavior Therapy (DBT). The major focus of the chapter is describing the current state of the literature evaluating the application of behavioral and cognitive behavior therapies to a range of clinical problems, including anxiety, eating disorders, depression, bipolar disorder, schizophrenia, and personality disorders. Specific interventions, such as exposure and response prevention, are discussed within the context of the disorder they were designed to treat. Major research findings are reported, and modifications to standard treatment applications are reviewed when relevant (e.g., the inclusion of partners or families in treatment). Summaries and conclusions are provided, and future directions are discussed.
ER  - 

TY  - JOUR
TI  - Print Only
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 9780470619049
UR  - https://doi.org/10.1111/jgh.12363_3
DO  - doi:10.1111/jgh.12363_3
SP  - 694
EP  - 919
PY  - 2013
ER  - 

TY  - JOUR
TI  - ASBMR 19th annual meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 12
IS  - S1
SN  - 9780470619049
UR  - https://doi.org/10.1002/jbmr.5650120103
DO  - doi:10.1002/jbmr.5650120103
SP  - S1
EP  - S531
PY  - 1997
ER  - 

TY  - JOUR
TI  - Paper Abstract
JO  - Journal of the American Geriatrics Society
JA  - J Am Geriatr Soc
VL  - 67
IS  - S1
SN  - 9780470619049
UR  - https://doi.org/10.1111/jgs.15898
DO  - doi:10.1111/jgs.15898
SP  - S1
EP  - S384
PY  - 2019
ER  - 
